ClinicalTrials.gg
RecruitingNCT07851090COSTUpdated Oct 1, 2026

Anger, Social Cognition and Post-traumatic Stress Disorder in Former French Military Personnel

An observational study in Post Traumatic Stress Disorder, sponsored by Direction Centrale du Service de Santé des Armées. Recruiting at 1 site in France. Open to participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2026-10-01.

Sponsored by Direction Centrale du Service de Santé des Armées · Observational

How we know

From the registry’s dates

  • Started May 2025; still recruiting 1 year 5 months later.
Updated Oct 1, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
150
Ages
18 Years to 45 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 144 studies in Stress Disorders, Post-Traumatic with a site in France — 33 open to participants now, 33 under way, 3 of them phase 3. Stress Disorders, Post-Traumatic · France.

Planned enrollment
28th of 63
150 · median 106
Started
2025
with 10 others
Observational
63 of 144
12 open now
Primary completion
2029-11
later than 30 of 32 live
Registered
141st of 144
by date
Lead sponsor
8 of 144
Direction Centrale du Service de Santé des Armées

Among the 144 studies in Stress Disorders, Post-Traumatic with a site in France, this one is the 28th largest by planned enrollment of the 63 observational ones that give a count, is one of 11 that started in 2025, is one of 63 observational ones, reaches primary completion later than 30 of the 32 other live ones, and was the 141st registered.

Stress Disorders, Post-Traumatic

2,689 studies on the registry are indexed under Stress Disorders, Post-Traumatic; 605 are open to participants now.

Browse Stress Disorders, Post-Traumatic studies →

Open to participants now

33 of the 144 studies in Stress Disorders, Post-Traumatic with a site in France are open now. Recruiting first, the newest first:

27 more — sign in →

All 33 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 416 Stress Disorders, Post-Traumatic studies recruiting now, 188 (45%) set no upper age limit and 202 (49%) stop at 75 or younger; 62 take children under 18; 88 take healthy volunteers.

This study: 18 Years to 45 Years · all sexes.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 144 studies in Stress Disorders, Post-Traumatic with a site in France, or all of them as a file.
02

Study summary

This is a single-center cross-sectional study conducted on a sample of former military personnel who had been diagnosed with PTSD. The main objective of this study is to test a mediation model positing that PTSD increases individuals' levels of anger through its detrimental effect on social cognitive abilities (Quantitative component). The secondary objectives focus on the impact of alcohol consumption and ACE on the three components (theory of mind, emotional decoding, empathy) of social cognition (qualitative component). A second secondary objective aims to explore the moral harms reported by former military personnel through a qualitative analysis of semi-structured interviews (qualitative component).

Primary Objective (Quantitative Component): To examine the links between PTSD, anger, and social cognition among French veterans using mediation analyses. The aim is to test whether PTSD (independent variable) indirectly influences individuals' levels of anger (dependent variable) through its effect on social cognition (mediating variable).

Secondary Objectives:

  • Quantitative component: to examine other factors associated with PTSD that may influence social cognitive abilities, such as alcohol consumption and experiences of childhood abuse (Abuse Childhood Experience-ACE);
  • Qualitative component: to explore the psychological trauma experienced by military personnel through a qualitative analysis of semi-structured interviews.

Evaluation criteria:

Main Components:

Quantitative Component

Self-report scales for PTSD, anger, and empathy, as well as two social cognition tasks:

  • PCL-5 - Posttraumatic Checklist-5
  • STAXI-2 - Spielberger's State-Trait Anger Expression Inventory-2
  • EQ - Empathy Quotient
  • MASC - Movie for the Assessment of Social Cognition
  • TREF - Facial Emotion Recognition Test

Secondary:

  1. Quantitative component

    Self-reported scales of alcohol use, childhood abuse experiences, and anxiety and depression:

    • AUDIT - Alcohol Use Disorders Identification Test
    • ACE-IQ - Adverse Childhood Experiences-International Questionnaire
    • HADS - Hospital Anxiety and Depression Scale
  2. Qualitative component - Content of verbatim transcripts from semi-structured interviews
Read the detailed description

Former military personnel eligible for the study are identified by the Pension and Occupational Risks Service (SPRP) through a computerized selection process using a database of individuals who meet the eligibility criteria. The SPRP serves as the internal partner that provides the investigator with a database of pensioners identified as eligible for the study. Based on this list, which is compiled according to the inclusion criteria, the principal investigator is responsible for sending a recruitment letter (via email; Visit 1: group information session) to eligible participants to invite them to participate in the study. The SPRP serves as the study's information center. It is responsible for sending a recruitment letter by regular mail (Visit 1: group information session) to eligible participants to invite them to participate in the study. Following this, participants will contact the investigator, who will conduct the individual information session (Visit 2), verify the inclusion criteria, and obtain their verbal consent. Initially, the quantitative component of the study will be conducted via a web link that will be sent to participants so they can complete the online tests and questionnaires (see CRF-Parts 2 through 5) on a dedicated platform on their own (Visit 3). Next, participants who are eligible for the qualitative component of the study will be contacted by phone (visit 4) and, with their consent, will participate in a semi-structured interview (visit 5).

03

Conditions studied

  • Post Traumatic Stress Disorder

Keywords

  • PTSD
  • Social Cognition
  • Anger
  • veterans
04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
All
Sampling method
Probability sample

Study population

These are former French military personnel who have been out of active duty for more than 6 months and are receiving a military disability pension for PTSD.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Be of legal age and between 18 and 45 years old;
  • Be able to speak, read, and write French;
  • Have given oral consent after receiving an oral explanation of the study's objectives and procedures;
  • Sign a written, informed, and electronic consent form after reviewing an information sheet explaining the study's objectives and procedures;
  • Be enrolled in a social security program;
  • Receive a military disability pension (PMI) (temporary or permanent) of 20% or more.

Additional criterion for the qualitative component: reporting having been exposed to events that could be morally harmful (verified through a specific question in the sociodemographic questionnaire).

Exclusion criteria

Exclusion Criteria:

Pregnant and breastfeeding women;

  • Minors;
  • Individuals under administrative or judicial supervision;
  • Adults under legal guardianship;
  • Reservists who have not previously served on active duty;
  • Individuals who cannot be contacted in an emergency;
  • Physical conditions related to trauma, including head injuries;
  • Participants with a comorbid psychotic disorder;
  • Participants who regularly use illicit drugs
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
150 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. PCL-5 score

    Post-Traumatic Stress Disorder Checklist for DSM-5 score to evaluate PTSD symptom severity.

    Time frame: 1 week post-enrollment (at Visit 3)

  2. STAXI-2 Score

    State-Trait Anger Expression Inventory-2 score to evaluate anger expression.

    Time frame: 1 week post-enrollment (at Visit 3)

  3. EQ score

    Empathy Quotient score to evaluate empathy.

    Time frame: 1 week post-enrollment (at Visit 3)

  4. MASC score

    Movie for the Assessment of Social Cognition score to evaluate social cognition.

    Time frame: 1 week post-enrollment (at Visit 3)

  5. TREF score

    Test de Reconnaissance des Émotions Faciales score to evaluate facial emotion recognition.

    Time frame: 1 week post-enrollment (at Visit 3)

  6. AUDIT score

    Alcohol Use Disorders Identification Test score to evaluate alcohol consumption.

    Time frame: 1 week post-enrollment (at Visit 3)

  7. ACE-IQ score

    Adverse Childhood Experiences International Questionnaire score.

    Time frame: 1 week post-enrollment (at Visit 3)

  8. HADS score

    Hospital Anxiety and Depression Scale score to evaluate anxiety and depression.

    Time frame: 1 week post-enrollment (at Visit 3)

07

Study locations

1 of 1 sites recruiting
  • Marmuse Anaïs
    Draguignan, 83300, France
    Recruiting
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started May 2025 (actual). Primary completion is estimated for Nov 2029, 54 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 24, 2026
First posted
Oct 1, 2026
StartActual
May 30, 2025
Primary completionEst.
Nov 30, 2029
CompletionEst.
Nov 30, 2029
Last update
Oct 1, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 1, 2026
Show all 1 update
  1. Oct 1, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07851090
Lead sponsor
Direction Centrale du Service de Santé des Armées
Responsible party
Sponsor
First posted
Oct 1, 2026
Start date
May 30, 2025
Primary completion
Nov 30, 2029 (estimated)
Completion
Nov 30, 2029 (estimated)
Last update
Oct 1, 2026

Study contacts

Anaïs Marmuse, PhD
Contact
anais.marmuse@intradef.gouv.fr
+336.42.89.18.97
Anaïs Marmuse, PhD
principal investigator · Service Santé des Armées
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion